205 Views

Patient Forum

Thursday, March 28, 2024

1:30 PM – 3:00 PM MDT

Chair(s)

John Wagner, MD, PhD (he/him/his)

Chief Medical Officer
Koneksa Health

Speaker(s)

Diane Stephenson, PhD

Executive Director
Critical Path Institute
Sarah Zenner-Dolan (she/her/hers)

Patient
Critical Path For Parkinson's
Qi Liu, PhD

Associate Director for Innovation & Partnership, Office of Clinical Pharmacology
US Food and Drug Administration
Peter Schmidt, PhD (he/him/his)

Chief Scientific Officer
Rho, Inc.

Session Description

The ASCPT Patient Forum is a session that highlights the role innovation in translational science can play in patients’ lives and the role that patients can have in advancing science. Medical innovation is impacting Parkinson’s disease at a rapid pace, particularly in molecular diagnosis and digital outcome measurement, enabling advances in drug development. How do these developments affect people living with Parkinson’s? This year’s Patient Forum will feature Sarah Dolan, a patient with Parkinson’s disease who has been impactful regarding patient-centric outcome measures development. Joining the discussion will be Diane Stephenson, PhD, Executive Director, Critical Path for Parkinson's Consortium, Qi Liu, PhD, Associate Director for Innovation & Partnership at Office of Clinical Pharmacology, U.S. Food and Drug Administration, and Peter Schmidt, PhD, Chief Scientific Officer at the CRO Rho.